Evidence map›Paper›PMID 21992875›Full record

ArticleMolecular pharmacology2012

Tyrosine phosphorylation of the human serotonin transporter: a role in the transporter stability and function.

Balasubramaniam Annamalai, Padmanabhan Mannangatti, Obulakshmi Arapulisamy, Toni S Shippenberg, Lankupalle D Jayanthi, Sammanda Ramamoorthy

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Molecular pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. microPublication biology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Post-translational modifications of transporters.Pharmacology & therapeutics · 2018
    Review
  14. The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  15. Role of SHP2 protein tyrosine phosphatase in SERT inhibition by enteropathogenicAmerican journal of physiology. Gastrointestinal and liver physiology · 2017
    Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Balasubramaniam AnnamalaiDepartment of Neurosciences, Division of Neuroscience Research, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Padmanabhan Mannangatti
Obulakshmi Arapulisamy
Toni S Shippenberg
Lankupalle D Jayanthi
Sammanda Ramamoorthy
Medical University of South Carolina · US

Funding

Serotonin Transporter PhosphorylationR01MH062612 · NIMH · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAMAMOORTHY, SAMMANDA · 2002 to 2011
$2.4M
Norepinephrine Transport Regulation By PhosphorylationR01GM081054 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KALIVAS, PETER W · 2007 to 2011
$1.2M
Intramural NIH HHSNIGMS NIH HHS GM081054NIGMS NIH HHS R01 GM081054NIMH NIH HHS MH62612NIMH NIH HHS R01 MH062612
6 · The paper itself

Abstract

The serotonin (5-HT) transporter (SERT) regulates serotoninergic neurotransmission by clearing 5-HT released into the synaptic space. Phosphorylation of SERT on serine and threonine mediates SERT regulation. Whether tyrosine phosphorylation regulates SERT is unknown. Here, we tested the hypothesis that tyrosine-phosphorylation of SERT regulates 5-HT transport. In support of this, alkali-resistant (32)P-labeled SERT was found in rat platelets, and Src-tyrosine kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4,d]pyrimidine (PP2) decreased platelet SERT function and expression. In human placental trophoblast cells expressing SERT, PP2 reduced transporter function, expression, and stability. Although siRNA silencing of Src expression decreased SERT function and expression, coexpression of Src resulted in PP2-sensitive increases in SERT function and expression. PP2 treatment markedly decreased SERT protein stability. Compared with WT-SERT, SERT tyrosine mutants Y47F and Y142F exhibited reduced 5-HT transport despite their higher total and cell surface expression levels. Moreover, Src-coexpression increased total and cell surface expression of Y47F and Y142F SERT mutants without affecting their 5-HT transport capacity. It is noteworthy that Y47F and Y142F mutants exhibited higher protein stability compared with WT-SERT. However, similar to WT-SERT, PP2 treatment decreased the stability of Y47F and Y142F mutants. Furthermore, compared with WT-SERT, Y47F and Y142F mutants exhibited lower basal tyrosine phosphorylation and no further enhancement of tyrosine phosphorylation in response to Src coexpression. These results provide the first evidence that SERT tyrosine phosphorylation supports transporter protein stability and 5HT transport.

Indexed as

AnimalsBlood PlateletsCell LineHumansPhosphorylationProtein StabilityRatsSerotonin Plasma Membrane Transport ProteinsTyrosineSerotonin Plasma Membrane Transport ProteinsTyrosine

Identifiers

PMID21992875
PMCPMC3250108
OpenAlexW1994195073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.